Singapore, June 30 -- Vetter, a globally operating Contract Development and Manufacturing Organisation (CDMO), recently celebrated the start of construction for its new clinical manufacturing site in Des Plaines with an official groundbreaking ceremony.

The independent pharmaceutical service provider received the building permit for the new site in April of this year. With an investment of approximately $285 million, this new facility underscores Vetter's dedication to delivering high-quality services and drug products during early clinical development.

Upstream and ground preparation work on the premises started back in April. Vetter's construction plans include a 160,000 square foot clinical production facility for aseptic manufacturi...